Clinical Trial Update: A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of intravenous TD-8954, a 5-HT4 receptor agonist, in healthy subjects; the trial was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Motility Disorder

Drugs mentioned

• TD-8954 (TD-8954)

Snippet

Sponsor: Theravance Biopharma | Conditions: Gastrointestinal Motility Disorder | Phase 1 | Status: TERMINATED | Results posted: 2017-08-02